Graphy 121announces paid-in capital increase; Aprogen and iA disclose convertible bonds
7On 13day, Graphy decided on a third-party allotment paid-in capital increase worth 120hundred million 9,979ten thousand 38won, while Aprogen and iA each disclosed convertible bonds worth 3hundred million won and 20hundred million won, respectively. BL Pharmtech’s stake in Kwangdong Health Bio rose to 50% after additional share purchases, and Eugene Technology decided on a bonus issue of common shares at 14shares for every one existing share, with 1shares issued per 0.2share.
Today(7day), listed companies on the KOSDAQ and KOSPI markets released a series of funding disclosures. The largest was the third-party allotment paid-in capital increase decided by Graphy, worth 13hundred million 120ten thousand 9,979won.38,3.
Graphy disclosed that it will raise 120hundred million 9,979ten thousand 38won, including funds for acquiring securities of other companies, through the issuance of new shares. The third-party allotment includes Korea Securities Finance Corp. and others, and the number of common shares outstanding before the capital increase is stated as 3ten thousand shares.1,117.
Aprogen disclosed that it will issue 32series convertible bonds worth 20hundred million won.
Aprogen's conversion price is 2,437won, and the start date of the conversion request period was announced as 2027year 7month 24day.
IA said it will issue 9-th convertible bond 50billion won.
IA's conversion price is 2,573won, and it announced that the conversion request period starts on 2027year 7month 21day.
BL Pharmtech said it additionally acquired 727,272shares of Kwangdong Health Bio for 10billion won.
After the additional acquisition, BL Pharmtech's stake in Kwangdong Health Bio was announced as 14%.
Eugene Technology said it decided to carry out a bonus issue of common shares, allotting 1shares per 0.2shares.